Regeneron Pharmaceuticals on Pace for Largest Percent Decrease Since November 2023 — Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $1016.40, down $28.27 or 2.71%

--Would be lowest close since June 11, 2024, when it closed at $1010.54

--On pace for largest percent decrease since Nov. 9, 2023, when it fell 2.74%

--Currently down two consecutive days; down 3.84% over this period

--Worst two day stretch since the two days ending June 28, 2023, when it fell 10.75%

--Up 15.72% year-to-date

--Down 5.12% from its all-time closing high of $1071.19 on June 25, 2024

--Up 41.59% from 52 weeks ago (July 5, 2023), when it closed at $717.83

--Down 5.12% from its 52-week closing high of $1071.19 on June 25, 2024

--Up 46.78% from its 52-week closing low of $692.45 on July 7, 2023

--Traded as low as $1011.67; lowest intraday level since June 12, 2024, when it hit $1009.14

--Down 3.16% at today's intraday low; largest intraday percent decrease since April 25, 2024, when it fell as much as 3.29%

--Third worst performer in the S&P 500 today

--Second worst performer in the Nasdaq 100 today

--Ninth least active stock in the Nasdaq 100 today

All data as of 11:07:04 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 03, 2024 11:24 ET (15:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.